Mechanistically, NSD2 directly governed the transcriptional activation of Ern1 through H3K36me2, thus activating the ERN1–JNK axis to exacerbate intestinal barrier impairment and subsequently promote NASH progression. The gene discussed is ERN1; the disease is metabolic dysfunction-associated steatohepatitis.